79 - High-Molecular Weight DNA Extraction and Nanopore Sequencing of PC-3 Cancer Cells for Genomic Analysis

Description/Abstract/Artist Statement

Prostate cancer is highly prevalent, affecting approximately 1 in 8 men throughout their lifetime. Advancing treatment options increasingly depends on comprehensive genomic analysis. Nanopore sequencing is a cutting-edge technology capable of generating ultra-long reads upwards of 100,000 base pairs, providing improved detection of structural variants, epigenetic modifications, and complex genomic rearrangements compared to traditional short-read sequencing methods. In this work, we cultured PC-3 prostate cancer cells and performed high-molecular weight DNA extraction, a technique to isolate and preserve long genomic fragments. The extracted DNA will be assessed for quality and size before being used for nanopore sequencing. The resulting read quality and coverage will also be assessed. Findings from this study may enhance our understanding of prostate cancer genomics, potentially informing biomarker discovery and therapeutic innovation in precision oncology.

Presenting Author Name/s

Bryan Hawickhorst

Faculty Advisor/Mentor

Harold Riethman

Faculty Advisor/Mentor Department

School of Medical Diagnostic and Translational Sciences

College Affiliation

Ellmer College of Health Sciences

Presentation Type

Poster

Disciplines

Cancer Biology | Genomics | Molecular Biology

This document is currently not available here.

Share

COinS
 

79 - High-Molecular Weight DNA Extraction and Nanopore Sequencing of PC-3 Cancer Cells for Genomic Analysis

Prostate cancer is highly prevalent, affecting approximately 1 in 8 men throughout their lifetime. Advancing treatment options increasingly depends on comprehensive genomic analysis. Nanopore sequencing is a cutting-edge technology capable of generating ultra-long reads upwards of 100,000 base pairs, providing improved detection of structural variants, epigenetic modifications, and complex genomic rearrangements compared to traditional short-read sequencing methods. In this work, we cultured PC-3 prostate cancer cells and performed high-molecular weight DNA extraction, a technique to isolate and preserve long genomic fragments. The extracted DNA will be assessed for quality and size before being used for nanopore sequencing. The resulting read quality and coverage will also be assessed. Findings from this study may enhance our understanding of prostate cancer genomics, potentially informing biomarker discovery and therapeutic innovation in precision oncology.